Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patients
Tetsuya Ogawa(Nihon University), Kosaku Nitta(Tokyo Women's Medical University), Ai Kyono(Tokyo Women's Medical University Adachi Medical Center), H Sugimoto(Tokyo Women's Medical University), Masayo Sato(Tokyo Women's Medical University), Kuniaki Otsuka(University of Minnesota)
Cited by 10
Related Papers
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
|Renal Replacement Therapy|2020|170
Left Ventricular Hypertrophy Is Associated with Arterial Stiffness and Vascular Calcification in Hemodialysis Patients
|Hypertension Research|2004|161
Annual dialysis data report 2017, JSDT Renal Data Registry
|Renal Replacement Therapy|2019|158